# Splicing variants in MYRF cause partial loss of function in the retinal pigment epithelium leading to nanophthalmos

**Authors:** Gabrielle M. Rozumek, Michelle L. Brinkmeier, Bin Guan, Su Qing Wang, Catherine Tower, Nina T. Yang, Rachel S. Lim, Dejuan Kong, Daniel Soden, Qitao Zhang, John Y.S. Han, Jason M.L. Miller, Lijin Dong, D. Ford Hannum, Sayoko E. Moroi, Julia E. Richards, Robert B. Hufnagel, Lev Prasov

PMC · DOI: 10.1172/jci.insight.194681 · JCI Insight · 2026-02-26

## TL;DR

This study shows that specific MYRF gene variants cause small eye size without other symptoms, but complete loss of MYRF function leads to more severe disease.

## Contribution

Identifies hypomorphic MYRF alleles as the cause of isolated nanophthalmos and reveals a tissue-specific threshold effect.

## Key findings

- dG-MYRF reduces target gene expression in RPE cells without affecting cleavage or localization.
- MyrfhumdG/humdG mice are embryonic lethal, showing a milder effect than complete MYRF knockout.
- Splicing variants in MYRF create nonfunctional isoforms linked to isolated nanophthalmos.

## Abstract

Improper light focus on the retina, refractive error, is primarily caused by eye size differences and is the leading cause of vision loss worldwide. C-terminal variants in the Myelin regulatory factor (MYRF) gene, a retinal pigment epithelium–derived (RPE-derived) transcription factor, lead to isolated nanophthalmos characterized by a small, though structurally sound eye. However, other MYRF loss-of-function variants cause syndromic disease. To address this discrepancy, in vitro and animal studies were performed on a pathogenic C-terminal variant dG-MYRF (p.Gly1126fs30*, c.3376-1G>A). Human RPE cells or primary RPE transduced with dG-MYRF showed reduced target gene expression, with decreased steady-state levels of the C-terminal cleavage product, but normal cleavage and localization. A homozygous humanized MYRF C-terminal mouse model (MyrfhumdG/humdG) was embryonic lethal by E18.5, while WT (MyrfhumWT/humWT) mice were viable. Single-cell RNA-seq from E17.5 MyrfhumdG/humdG and KO RxCre;Myrffl/fl (E15.5 and P0) mice revealed shared differentially expressed genes, with decreased effect size in the MyrfhumdG/humdG eyes. These findings support dG-MYRF as a hypomorphic allele. Additionally, 2 MYRF splicing variants creating nonfunctional isoforms were found in families with isolated nanophthalmos. Overall, hypomorphic MYRF alleles underlie isolated nanophthalmos, supporting a tissue-specific threshold effect and highlighting unique roles for the MYRF C-terminus in the RPE.

Dominant variants in MYRF partially altering gene function or dosage may lead to ocular disease only while total loss-of-function may lead to syndromic disease.

## Linked entities

- **Genes:** MYRF (myelin regulatory factor) [NCBI Gene 745], MYRF (myelin regulatory factor) [NCBI Gene 745]
- **Proteins:** MYRF (myelin regulatory factor)
- **Diseases:** nanophthalmos (MONDO:0021129)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** Myrf (myelin regulatory factor) [NCBI Gene 225908] {aka 6030439E18, Gm1804, Gm98, Mrf}
- **Diseases:** refractive error (MESH:D012030), embryonic lethal (MESH:D020964), vision loss (MESH:D014786), syndromic disease (MESH:D004194), nanophthalmos (MESH:C563983)
- **Chemicals:** MyrfhumdG (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** p.Gly1126fs30, c.3376-1G>A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13043084/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13043084/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC13043084/full.md

---
Source: https://tomesphere.com/paper/PMC13043084